The long-term effects of lamivudine treatment in patients with HBeAg-negative liver cirrhosis

KILIÇ Z. M. Y., KURAN S., AKDOĞAN M., ÇİÇEK B., Oguz D., Odemis B., ...Daha Fazla

ADVANCES IN THERAPY, cilt.25, sa.3, ss.190-200, 2008 (SCI-Expanded, Scopus) identifier identifier identifier identifier

  • Yayın Türü: Makale / Tam Makale
  • Cilt numarası: 25 Sayı: 3
  • Basım Tarihi: 2008
  • Doi Numarası: 10.1007/s12325-008-0038-6
  • Dergi Adı: ADVANCES IN THERAPY
  • Derginin Tarandığı İndeksler: Science Citation Index Expanded (SCI-EXPANDED), Scopus
  • Sayfa Sayıları: ss.190-200
  • Çukurova Üniversitesi Adresli: Hayır

Özet

Introduction: In hepatitis B virus(HBV)-related liver cirrhosis, patients with HBV replication show a higher mortality rate than those without. We aimed to investigate the long-term effects of lamivudine on HBV DNA suppression, Child-Pugh score, and survival in patients with hepatitis Be antigen (HBeAg)-negative liver cirrhosis.